Why is Lung Cancer Research Important?
Research investment saves lives! To understand the disease, improve detection methods and develop new treatments that will help double lung cancer survival by 2022, scientists must conduct research.

There is Not Enough Funding For Lung Cancer Research
Lung cancer claims more lives each year than breast, colon and prostate cancer combined. Yet lung cancer receives proportionately less government funding per death than other types of cancer.

This means private funding for lung cancer research, such as the Partnership provides, is crucial to developing lifesaving treatments.

Research Updates
Visit the National Lung Cancer Partnership's website for the latest articles and press releases about research breakthroughs and new treatments!

Partnership Research Grants
Since 2005, the Partnership has awarded more than $3.7 million for cutting-edge research that is essential to helping patients live longer and better lives. 

The Partnership is currently sponsoring Young Investigator Research Grants, which support researchers early in their careers and ignite their interest in lung cancer research.

This grant program is designed to complement the National Institutes of Health lung cancer research program; the Partnership provides researchers the ground-level support they need to prove their ideas are substantial enough to receive more extensive funding from the federal government.

These Young Investigator Research Grants are fueling novel ideas across a wide variety of lung cancer research areas that have long been underfunded, including:

• Early detection
• How the body’s immune system responds to treatment
• Genetic components and risk factors of the disease
• How a tumor’s environment affects its growth

Visit the National Lung Cancer Partnership's website to read about the cutting-edge research the Partnership's Young Investigator Research Grant Program is funding!